Get the app
USHealthcare

Quidel Corporation (QDEL)

US · Healthcare · Medical Devices

$11.09+2.97%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$630.9M
Revenue YoY
+2.8%
Net profit
$-92.9M
EPS
$0.13
EPS estimate
$-0.04
Net margin
-14.7%

EPS came in at 0.13 against a street estimate of -0.04 — a beat of 425.0%.

Key statistics

Market cap
$807.8M
Forward P/E
7.2
P/B
0.46
Book value
$25.99
EPS (TTM)
$-15.43
52-week high
$35.58
52-week low
$9.92
50-day MA
$15.61
200-day MA
$19.26
Beta
0.68

Analyst view

Analysts rate Quidel Corporation a buy (5 buy, 2 hold, 1 sell out of 8) with an average price target of $14.67.

Shareholding

Insiders
0.89%
Institutions
124.69%

Largest institutional holders

FundStake
BlackRock Inc15.24%
FMR Inc9.61%
T. Rowe Price Investment Management,Inc.8.21%
Newtyn Management LLC6.65%
Vanguard Portfolio Management, LLC5.88%
American Century Companies Inc4.82%
Rubric Capital Management LP4.82%
Amvescap Plc.4.55%

Recent filings & reports

DocumentDate
Quarterly report · Q2 FY2027
QUIDELORTHO CORPORATION - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues Q2 2026: $630.9 million (vs. $613.9 million Q2 2025, +2.8%) • Total
2026-08-07
Results announced · Q3 FY2027
QUIDELORTHO CORPORATION – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Total Revenue: $630.9 million, +3% reported / +2% constant currency vs
2026-08-06
Board / officer change · Q2 FY2027
QUIDELORTHO CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • New CFO Appointment: Micah Young appointed Chief Financial Officer effective July 6, 2
2026-06-23
Shareholder vote results · Q2 FY2027
QUIDELORTHO CORPORATION (QDEL) - 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held on June 16, 2026 • Total votes cast for director
2026-06-16
Quarterly report · Q1 FY2027
QUIDELORTHO CORPORATION – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues Q1 2026: $619.8 million vs. $692.8 million in Q1 2025 (down 10.5% y
2026-05-06
Results announced · Q2 FY2027
QUIDELORTHO CORPORATION – Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenue: $619.8 million, down 10.5% year-over-year (down 12.6% in consta
2026-05-05
Proxy statement · Q2 FY2027
QUIDELORTHO CORPORATION — 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of 10 Director Nominees — Vote FOR ALL
2026-04-27
Annual report FY2025
QUIDELORTHO CORPORATION – FORM 10-K SUMMARY Fiscal Year Ended December 28, 2025 --- HEADLINE NUMBERS • Market capitalization: $1,940,523,408 based
2026-02-19

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Quidel Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.